Frequently Asked Questions

Diagnosis & The "Diagnostic Odyssey"

Confirmation requires a “two-key” approach to end the average 7-year search for a name:

  • Genetic Testing: Early sequencing of the MVK gene can identify mutations. While this is a vital first step, genetic variants can sometimes be “inconclusive.”
  • The Enzyme Gold Standard: To definitively confirm MKD, doctors measure the biochemical activity of the mevalonate kinase enzyme. In MKD patients, this activity is typically reduced to between undetectable and 20% of normal function.
  • Where is the test done?  The Netherlands: Currently, the primary global reference center for this specialized testing is Erasmus MC/Amsterdam UMC.
  • Emerging Assays: While the Netherlands lab is the standard, other international research institutions are actively exploring and validating new assays to replicate this enzyme test and make it more widely accessible. Stay tuned for more updates to this section as new information becomes available.

Symptoms & The Scientific "Why"

MKD exists on a phenotypic continuum, meaning it looks different for everyone. Symptoms often appear in infancy and include:

  • The “Classic” Flare: Recurring high fevers (3–7 days), skin rashes (red spots or patches), abdominal pain, vomiting, and joint swelling.
  • Eye Involvement (Crucial): Uveitis: Inflammation inside the eye that can lead to permanent vision loss if not treated. If your child has red, painful, or light-sensitive eyes during a flare, see an ophthalmologist immediately.
  • Cataracts: Clouding of the eye’s lens, often seen in more severe cases.
  • Neurological & Organ Issues: Developmental delay, ataxia (balance issues), and enlargement of the liver or spleen (hepatosplenomegaly). Annual brain MRI may be suggested as a preventative measure. Ultrasounds of crucial organs may also be required according to individual symptoms / blood test results i.e. liver.
Imagine every cell as a factory with a production line called the mevalonate pathway. This line creates molecules called isoprenoids. These molecules are the “off-switch” (or “brakes”) for your immune system. In MKD, the production line is broken. The shortage of isoprenoids causes defective protein prenylation, which means the “brakes” fail. Your innate immune system stays “on,” causing the systemic inflammation that attacks the skin, joints, and eyes.

The mevalonate kinase enzyme is temperature sensitive. When a child has a minor infection or is under high stress, their body temperature rises slightly. This extra heat causes the already defective enzyme to work even less efficiently. This creates a “vicious cycle”: the higher the temperature, the less the enzyme works, leading to more inflammation and even higher fevers.

Managing the Disease & Speaking to Doctors

Standard blood tests often do not accurately reflect the “fire” of an MKD flare. Ensure your specialist is tracking these specific markers as well as any others based on your specific symptoms:

  • CRP (C-Reactive Protein): To measure active, systemic inflammation.
  • SAA (Serum Amyloid A): This is critical. High SAA levels, even between fevers, can indicate “sub-clinical” inflammation that puts organs like the kidneys at risk for long-term damage (amyloidosis).
  • Ferritin: High levels can help doctors monitor for rare but serious complications like Macrophage Activation Syndrome (MAS).

Because MKD is rare, you are often the “expert” on your child’s specific case.

  • Symptom Tracking: Keep a rigorous log of fevers, rashes, and any eye redness or pain. Data on the frequency and duration of flares is more useful to a doctor than a single data point.
  • The Medical Binder: Keep copies of all Genetic and Enzyme Activity reports and historical blood work trends.
  • The Vaccine Log: Record every immunization date and brand. Because vaccines raise body temperature and trigger an immune response, they are known triggers for MKD flares. Having this record allows your doctor to plan “pre-treatment” (like a temporary dose of an IL-1 blocker) to make future vaccines safer. There may also be specific vaccines not recommended by your specialist.

Treatment & Support

Current therapies focus on blocking the “fire” signals (cytokines) that cause the body to attack itself:

  • IL-1 Inhibitors (First-Line): Medications like Anakinra and Canakinumab target Interleukin-1, the main driver of MKD inflammation. These have significantly improved outcomes for many patients.
  • TNF Blockers: Drugs like Etanercept are sometimes used but are often less consistent than IL-1 blockers.
  • Corticosteroids: Rescue Medication / Short-term Bridge during flare
  • Build Connections via Relevant Facebook Groups:
    1. HIDs and MA: Education and Support FB Group
    2. MKD Facebook Group
    3. Autoinflammatory Diseases Facebook Group
  • Professional Advocate, Rachel Rimmer: Connect with Rachel Rimmer at RACC UK. You can book video consultations and get supporting letters for schools or employers that explain the complexities of MKD care.
  • Autoinflammatory Alliance Board Member and HIDs Mom, Jennifer Tousseau: Reach out to Jennifer via the HIDs and MA: Education and Support FB Group with questions
  • MKD Community Calls: Join our Patient Calls to connect with other families who have navigated this same odyssey.
  • Mental Health Support: Diagnostic delay and chronic illness are traumatic. Reach out to Rare Minds or the Global Genes RARE Concierge for specialized counseling resources. If you are looking for a private therapist in your area, use these “search filters” or keywords to find someone who understands. Search Keywords: “Medical Trauma,” “Chronic Illness,” “Grief and Loss,” or “Caregiver Stress.” Ask in the Initial Call: “Have you worked with families facing rare or life-limiting illnesses before? Do you understand the trauma associated with frequent hospitalizations or diagnostic odysseys?” You can also look for “Health Psychologists”: These are therapists specifically trained in the intersection of physical health and mental well-being.
Donate
Donate